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Prebiotics are used to influence the growth, colonization, survival, and activity of pro-
biotics, and enhance the innate immunity, thus improving the health status of the host.
The survival, growth, and activity of probiotics are often interfered with by intrinsic factors
and indigenous microbes in the gastrointestinal tract. In this study, Bulnesia sarmienti
aqueous extract (BSAE) was evaluated for the growth-promoting activity of different strains
of Lactobacillus acidophilus, and a simple, precise, cost-effective high-performance liquid
chromatography (HPLC) method was developed and validated for the determination of
active prebiotic ingredients in the extract. Different strains of L. acidophilus (probiotic) were
incubated in de Man, Rogosa, and Sharpe (MRS) mediumwith the supplementation of BSAE
in a final concentration of 0.0%, 1.0%, and 3.0% (w/v) as the sole carbon source. Growth of
the probiotics was determined by measuring the pH changes and colony-forming units
(CFU/mL) using the microdilution method for a period of 24 hours. The HPLC method was
designed by optimizing mobile-phase composition, flow rate, column temperature, and
detection wavelength. The method was validated according to the requirements of a new
method, including accuracy, precision, linearity, limit of detection, limit of quantitation,
and specificity. The major prebiotic active ingredients in BSAE were determined using the
validated HPLC method. The rapid growth rate of different strains of L. acidophilus was
observed in growth media with BSAE, whereas the decline of pH values of cultures varied in
different strains of probiotics depending on the time of culture. (þ)-Catechin and ()-epi-
catechin were identified on the basis of their retention time, absorbance spectrum, and
mass spectrometry fragmentation pattern. The developed method met the limit of all
validation parameters. The prebiotic active components, (þ)-catechin and ()-epicatechin,
were quantified as 1.27% and 0.71% (w/w), respectively, in crude extract, and 6.36 ± 0.06 mg/
mL and 4.47 ± 0.41 mg/mL (mean ± standard deviation), respectively, in a prebiotic capsuleoratory of Veterinary Pharmacokinetics and Pharmacodynamics, 80 Daehakro, College of
niversity, Daegu, 702-701, South Korea. Tel.: þ82 109 771 0761 (mobile), þ82 539 505 964.
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It has been known for more than 3 decades that the human
body contains 10-fold more microbial cells (1014) than
human cells [1]. Intestinal microbes are important for the
improvement of a healthy, stable intestinal tract and im-
mune system [2]. The health-promoting effects of microflora
enhance immunostimulation and vitamin synthesis, and
inhibit the growth of pathogenic organisms [3]. There are
different genera of microbes that are being used as pro-
biotics. In particular, lactobacilli, bifidobacter, and yeast
have been developed as potential probiotics that provide
nutrients to intestinal cells, increase intestinal absorption,
and maintain the gut environment and immune system
[4e6]. The therapeutic uses of probiotics have become a
growing research interest in human infectious, inflamma-
tory, and allergic diseases because of its potential health
benefit effects [7]. The ingestion of probiotics and prebiotics,
or the combination of both (synbiotic) indicates a novel new
therapeutic strategy [8]. Prebiotics are nondigestible carbo-
hydrate ingredients that selectively stimulate the growth,
activity, survival, and/or colonization of probiotics in the
large intestine by providing a fermentable carbon source
without inducing the growth of intestinal pathogens, such
as Clostridium perfringens [9,10]. Currently, prebiotics are
widely used to enhance the growth of gut microflora, and
induce mineral absorption, lipid metabolism, and innate
immunity [11].
Prebiotic oligosaccharides can be produced in three
different ways: by extraction from plant materials, microbio-
logical synthesis or enzymatic synthesis, and enzymatic hy-
drolysis of polysaccharides [12]. Plants are one of the potential
sources of prebiotics, and the extract of Bulnesia sarmienti
could be an opportunistic agent for the management of gut
microflora. B. sarmienti is a wood with aromatic incense used
as traditional medicine for centuries. It is found in the area of
Gran Chaco of South America. In folk medicine, its essence
has been used for skin healing. The bark has also been used as
a tonic for stomach ailments and for treatment of cardiovas-
cular disorders, diabetes, and some cancers. The antitumor,
antioxidant, anti-inflammatory, and antithrombosis activities
of B. sarmienti extract have been previously reported [13].
However, information on the prebiotic action of B. sarmienti is
limited, and of low scientific caliber. The flavonoids,
(þ)-catechin (trans-3,39,49,5,7-pentahydroxy-flavan) and
()-epicatechin (cis-3,39,49,5,7-pentahy-droxyflavan), were
reported to have prebiotic effects [14]. Interestingly, B. sar-
mienti extract contains large amounts of (þ)-catechin and
()-epicatechin [13,15], similar to some other fruits and plant-
derived foods [16,17]. The interest in these compounds isgrowing rapidly because of their versatile pharmacological
effects. Several analytical techniques including some high-
performance liquid chromatography (HPLC) methods with
different detection modes have been reported [18,19]. How-
ever, there is an exigent need for a simple, precise, rapid, and
cost-effective HPLC method for the simultaneous separation
and quantification of catechin and epicatechin in view of the
increasing attention they receive.
Thus, the present study was designed to investigate the
possible prebiotic action of B. sarmienti aqueous extract (BSAE)
to influence the growth of specific gut microbes. Another aim
was to develop and validate an easy, beneficial HPLC method
for the determination of active prebiotic ingredients,
(þ)-catechin and ()-epicatechin, in plant extracts and herbal
products that would be appropriate to use in any analytical
laboratory.2. Materials and methods
2.1. Chemicals and reagents
HPLC-grade methanol was purchased from Honeywell Bur-
dick & Jackson (Muskegon, MI, USA). Deionized water was
purified in a Milli-Q System (Millipore, Bedford, MA, USA).
Acetic acid was obtained from the Junsei Chemical Co. Ltd.
(Tokyo, Japan). (þ)-Catechin and ()-epicatechin were pur-
chased from Sigma (St. Louis, MO, USA), and the purity was
higher than 98% by HPLC analysis.
2.2. Probiotic strains and their growth conditions
The four Lactobacillus acidophilus strainsdKCTC 3140, KCTC
3146, KCTC 3154, and KCTC3179dwere obtained from the
Korea Collection for Type Cultures (KCTC, Daejeon, South
Korea). The KCTC 3140, KCTC 3146, KCTC 3154, and KCTC3179
strains of L. acidophilus were isolated from rat, pig, chicken,
and human gut, respectively. All strains were cultured in de
Man, Rogosa and Sharpe (MRS) broth (Difco, Detroit, MI, USA)
under anaerobic and aerobic conditions at 37C for 24 hours or
48 hours.
2.3. Preparation of BSAE
The dried bark of B. sarmienti was purchased from the Lucky
Pharmaceutics Company (Daegu, South Korea). The bark
was washed, sliced, and finally boiled in distilled water
(10 mL water/1 g of bark) in a round bottom boiling flask at
95C for 3 hours. The extract was cooled to room tempera-
ture, then filtered and solidified in a rotatory evaporator
under vacuum. The yield of extract from the dried bark of B.
Table 1 e Mobile-phase gradient.
Time
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suspended in distilled water and preserved at 20C until
use.
2.4. Culture of probiotic with BSAE
Optimum doses of BSAE were used in the MRS medium to
determine the growth of the four probiotic strains. BSAE was
supplemented in MRS medium (50 mL) at various concentra-
tions (0.0%, 1.0%, and 3.0%, w/v) as the sole carbon source.
After the media preparation, the inoculum of each probiotic
[1  109 colony-forming units (CFU)/mL] was cultured in BSAE
(prebiotic) containing MRS medium at 37C overnight (16
hours) under either aerobic or anaerobic conditions. The
growth of each strain was examined by measuring the CFUs
(CFU/mL) using a broth microdilution method.
2.5. Culture fermentation
The test carbohydrate was dissolved in MRS medium and
autoclaved for 15 minutes at 121C. Each inoculum of pro-
biotics (1  109 CFU/mL) was cultured in prepared MRS me-
dium (50 mL) supplemented with carbohydrate and BSAE at
different concentrations (0.0%, 1.0%, and 3.0%, w/v) as the sole
carbon source for overnight (16 hours) incubation at 37C. The
growth of each strain of probiotics was monitored via pH
changes in media and CFUs (CFU/mL) of the probiotics at
0 hours, 1 hour, 3 hours, 6 hours, 9 hours, 12 hours, and 24
hours. Next, a 3-mL culture from each tube was collected
aseptically at all time points and centrifuged (15 minutes,
5000 rpm, at 4C) to obtain the supernatant. The pH of the
culture supernatant was measured using a digital pH meter
(Orion, Model: 420A; Thermo Scientific, Waltham, MA, USA).
The pHmeter was standardized with pH 4 and 10 buffers prior
to use. A microdilution method was used to determine the
CFUs (CFU/mL) of culture at the designated time points.
2.6. Chromatographic analysis of BSAE
2.6.1. Instrumentation of chromatographic systems
The Agilent 1100 HPLC system (Agilent Technologies, Palo Alto,
CA, USA)was equippedwith anAgilent G1314AUVdetector. An
HP ODS Hypersil column (5 mm, 200 mm 4.6 mm) was used
for the separation of compounds. The temperature of the col-
umn compartment was maintained at 30C throughout the
analysis. The wavelength of detection was 280 nm and the
injection volume was 20 mL. All chromatographic runs were
carried out in a gradient mode with a flow rate of 1 mL/min. A
mixture of HPLC-grade methanol and 0.5% (v/v) acetic acid (pH
3.50) were exploited as themobile phase, and the ratio of eluent
A (methanol) and eluent B (0.5%, v/v acetic acid, pH 3.50) was
5:95 during the first 10 minutes of each run. The proportion of
“eluent A” was increased linearly to 60% (v/v) from 10 minutes
to 40minutes and then sustained for 2minutes. Thereafter, the
eluent was returned to the initial composition (eluent A: 5%, v/
v; eluent B: 95%, v/v) in 3 minutes, where it wasmaintained for
5minutes in order to re-equilibrate the column prior to another
injection (Table 1). The method was validated by checking the
accuracy, precision, linearity, limit of detection (LOD), limit of
quantitation (LOQ), and specificity prior to sample analysis.The Agilent 1946B mass selective detector (Agilent Technolo-
gies) was used with the above-mentioned HPLC system to
obtain the mass spectrum of (þ)-catechin and ()-epicatechin
(Figure 1). Other conditions of the system were the same as
those used in UV detection. The compounds were analyzed in
selected ionmonitoringmodeusingmass/charge ratios (m/z) of
289, 435, and 449.
2.6.2. Preparation of standard solution
Parent stock solutions (1 mg/mL) of (þ)-catechin and
()-epicatechin were separately prepared by dissolving in
50% (v/v) methanol in clear glass vials. A series of working
standards were prepared using the appropriate dilutions to
obtain concentrations of 1.56 mg/mL, 3.12 mg/mL, 6.25 mg/mL,
12.50 mg/mL, and 25.00 mg/mL in 0.5% (v/v) acetic acid. These
working standards were used in the determination of accu-
racy, precision, and linearity. All stock solutions and working
standard solutions were immediately stored at 4C.
(þ)-Catechin and ()-epicatechin in a concentration of
6.25 mg/mL were also freshly prepared in a similar manner
and used as control in the quantitation of those compounds
in the plant extract.
2.6.3. Preparation of sample solution
Ten capsules of BSAEwere cut into small pieces and put into a
50-mL conical tube, into which 10 mL methanol was added.
After vortexmixing for 15minutes and subsequent sonication
treatment for 1 minute, the mixture was centrifuged at 1200g
for 20 minutes. The supernatant was transferred to a clean
tube and diluted by 100 times with 0.5% (v/v) acetic acid.
Thereafter, the supernatant was passed through a 0.45-mm
filter and injected into the HPLC system. In the validation of
the analytical method, the extract samples were preanalyzed,
and the extract having the known amount of (þ)-catechin and
()-epicatechin was then spiked with extra 1.56 mg/mL,
6.25 mg/mL, and 25.00 mg/mL of (þ)-catechin and ()-epi-
catechin. Themixtureswere analyzed to check the recovery of
the added (þ)-catechin and ()-epicatechin at different levels
in the plant material. In a sample analysis, the dried extract
and capsule samples were prepared, similar to the procedure
mentioned above deprived of spiking with extra (þ)-catechin
and ()-epicatechin.
2.6.4. Validation of analytical method
The accuracy of an analytical method is the extent to which
test resultswere generatedby themethodand the true valueof
analytes. The precision of a method is the extent to which the
individual test results of multiple injections of a series of
standards agree. The working standards having 1.56 mg/mL,
Figure 1 e Chemical structures of (þ)-catechin and (¡)-epicatechin [18].
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catechin were injected six times into the HPLC system for the
determination of accuracy and precision of the analytical
method. The linearity of an analytical method is its ability to
elicit test results that are directly proportional to the concen-
tration of analytes in sampleswithin a given range. Linearity is
determined by a series of three injections of five
standardsd1.56 mg/mL, 3.12 mg/mL, 6.25 mg/mL, 12.50 mg/mL,
and 25.00 mg/mL of (þ)-catechin and ()-epicatechin. The
linear regression analysis was carried out by plotting the peak
areas (y-axis) of each compound against the respective con-
centrations (x-axis) of (þ)-catechin and ()-epicatechin. The
linearity for the relationship between peak area and concen-
tration was demonstrated by a correlation coefficient (r2) >
0.99. Recovery is expressed as the amount of analyte found in a
spiked sample as a percentage to the theoretical amount
thought to be present in the medium. The absolute recovery
rates of (þ)-catechin and ()-epicatechin from BSAE and cap-
sules of BSAEwere evaluated in three different concentrations
with triplicate analysis. The lower LOD is defined as the lowest
concentration of analyte in a sample that can be detected, but
not necessarily quantitated, under the stated experimental
conditions. It can be calculated from the standard deviation
(SD) of the response and the slope associated with the cali-
bration curve according to the equation: LOD ¼ (SD  3.3)/
slope. The lower LOQ is also similarly defined, but as the lowest
concentration of analyte in a sample that can be quantifiable
under the stated experimental conditions. It can also be
calculated from the SD of the response and the slope associ-
ated with the calibration curve, but according to the following
equation: LOQ ¼ (SD  10)/slope. The specificity of themethod
was ascertained by analyzing the standard compounds and
the extract. The peaks for (þ)-catechin and ()-epicatechin in
the sample were confirmed by comparing the retention times
of the sample peak with that of the standard. The peak purity
of those compoundswas assessed by comparing the spectra at
two levels: peak start (S) and peak end (E) positions.2.7. Data analysis
All data were calculated as means±SD, and multiple group
comparisons were performed using one-way analysis ofvariance, followed by the Duncan’s multiple range tests for
comparisons. Values not sharing the same letter were signif-
icantly different (p < 0.05). The statistical analysis was per-
formed using the SAS 9.4 software (SAS Institute, Cary, NC,
USA).3. Results and discussion
3.1. Effect of BSAE on growth of L. acidophilus strains
Within the lactic acid bacteria, the subgroup of the Lactoba-
cillus complex is of particular interest because many mem-
bers occupy important ecologic niches in the gastrointestinal
tracts of humans and animals, and L. acidophilus is probably
themost well-known species of this genus [20]. There are four
strains of L. acidophilusdKCTC 3140, KCTC 3146, KCTC 3154,
and KCTC 3179, which were isolated from rat, pig, chicken,
and human intestines, respectively. The different strainswere
cultured in MRS broth containing 0.0%, 1.0%, and 3.0% (w/v)
BSAE. The growth of four tested strains of L. acidophilus pro-
biotic was determined at 0 hours, 3 hours, 6 hours, 9 hours, 12
hours, and 24 hours. Among the four strains, the rapid growth
rate of L. acidophilus KCTC 3140 and L. acidophilus KCTC 3146
was found in MRS broth containing 3.0% (w/v) BSAE (Figures
2A and 2B), whereas the growth rate of L. acidophilus KCTC
3154 and KCTC 3179 was observed to be faster in MRS broth
containing 1.0% (w/v) BSAE (Figures 2C and 2D). During the
growth period of L. acidophilus KCTC 3140 and KCTC 3146,
there was no difference in pH values between 0.0%, 1.0%, and
3.0% (w/v) of BSAE in MRS broth (Figures 3A and 3B). Mean-
while, the pH of the growth medium of L. acidophilus KCTC
3154 and KCTC 3179 was decreased at 1.0% and 3.0% (w/v)
concentration of BSAE after 9 hours (Figures 3C and 3D). The
decrease in pH over time results from the breakdown of
lactose to form lactic acid. The lack of differences in pH of the
treatments comparedwith the control brothmay be caused by
the buffering capacity of the components of growth media
[21]. The prebiotic action of the said extract may be attribut-
able to the existence of two prebiotic active compounds,
(þ)-catechin and ()-epicatechin. Catechin and epicatechin
improve gut health; they also influence the growth of specific
Figure 2 e Growth curves of four Lactobacillus acidophilus strains. (A) L. acidophilus KCTC 3140 isolated from rat gut, (B) L.
acidophilus KCTC 3146 isolated from pig gut, (C) L. acidophilus KCTC 3154 isolated from chicken gut, and (D) L. acidophilus
KCTC 3179 isolated from human gut cultured in MRS broth in the absence of BSAE (A), and in the presence of 1.0% BSAE (-),
and 3.0% BSAE (:) (w/v). Culture sample was taken at designated times and spread on MRS plates to count surviving cells.
Results are presented from three independent analyses. Values not sharing the same letter are significantly different
(p < 0.05). BSAE¼ Bulnesia sarmienti aqueous extract; CFU ¼ colony forming units; MRS¼ de Man, Rogosa, and Sharpe.
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well as a number of probiotics increased by daily ingestion of
prebiotics [14,22].3.2. Development of method
In the current study, we developed the HPLC method in order
to identify and quantify (þ)-catechin and ()-epicatechin
simultaneously from an extract. Generally, it requires
several trials to select a suitable mobile phase and to develop
a method, because of the complexity of the chemical
composition of plant extracts and the affinities of the com-
ponents toward various solvents. The proportions of the
organic and aqueous phases were adjusted to obtain a rapid
and simple assay method with a reasonable runtime, suit-
able retention time, and sharp peak. The instruments under
the optimized conditions gave well-resolved symmetric
band for (þ)-catechin and ()-epicatechin from the pure
compounds as well as from the plant extract. In HPLC
chromatogram (Figure 4), peaks of pure compounds of
(þ)-catechin and ()-epicatechin were observed at the
retention times between 7 and 12 minutes. When the extractsolutions were injected six times, the retention times of
flavonoids present in extract were found to be the same with
some other unidentified peaks.3.3. Validation of method
3.3.1. Accuracy and precision
Accuracy and precision were determined from quality control
standards in three different concentrations by calculating the
percentage of accuracy and percentage of relative standard
deviation (%RSD), respectively, for each set of test samples.
Table 2 shows the accuracy, intraday precision (repeatability),
and interday precision (reproducibility) of this assay method.
The accuracy of the analysismethod obtained for (þ)-catechin
was 132.87 ± 0.05%, 97.71 ± 0.17%, and 102.64 ± 0.09% from the
injection of 1.56 mg/mL, 6.25 mg/mL, and 25.00 mg/mL of pure
compound, respectively. In the case of ()-epicatechin, the
method showed 94.81 ± 0.24%, 105.96 ± 0.07%, and
97.25 ± 0.08% accuracy for 1.56 mg/mL, 6.25 mg/mL, and
25.00 mg/mL of pure ()-epicatechin, respectively. The intra-
and interday precision of this assay method was within the
limits for all tested concentrations according to the guidelines
Figure 3 e Observation of pH changes in culture media using pH meter. pH tolerance of four Lactobacillus acidophilus
strainsd(A) L. acidophilus KCTC 3140 isolated from rat gut, (B) L. acidophilus KCTC 3146 isolated from pig gut, (C) L. acidophilus
KCTC 3154 isolated from chicken gut, and (D) L. acidophilus KCTC 3179 isolated from human gutdwas determined in culture
media during growth in MRS broth in the absence of BSAE (A), and in the presence of 1.0% BSAE (-) and 3.0% BSAE (:) (w/
v). Results are presented from three independent analyses. Values not sharing the same letter are significantly different
(p < 0.05). BSAE ¼ Bulnesia sarmienti aqueous extract; MRS ¼ de Man, Rogosa, and Sharpe.
Figure 4 e Representative PDA chromatogram and selected ion mass chromatograms of catechin and epicatechin with UV
detection at 280 nm. PDA¼ photodiode array.
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1.56 2.08 ± 0.02a 0.80 132.87 ± 0.05 1.93 ± 0.16a 8.23 123.65 ± 0.22
6.25 6.11 ± 0.08b 1.25 97.71 ± 0.17 6.04 ± 0.55b 9.20 96.56 ± 0.67
25 25.66 ± 0.05c 0.18 102.64 ± 0.09 25.15 ± 0.35c 1.41 100.60 ± 0.42
Epicatechin (mg/mL)
1.56 1.48 ± 0.17a 11.39 94.81 ± 0.24 1.48 ± 0.18a 11.89 94.81 ± 0.26
6.25 6.62 ± 0.03b 0.52 105.96 ± 0.07 6.62 ± 0.08b 1.23 105.92 ± 0.11
25 24.31 ± 0.05c 0.20 97.25 ± 0.08 24.55 ± 0.50c 2.05 98.21 ± 0.64
Results are presented from three independent analyses.
a,b,c Values not sharing the same letter are significantly different (p<0.05). Percent accuracies were determined from the individual precision
values.
RSD ¼ relative standard deviation; SD ¼ standard deviation.
Figure 5 e Standard calibration curves for the detection of
compounds. (A) Catechin. (B) Epicatechin. Results are
presented from three replicate injections.
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%RSD value is within the limits, indicating that the assay
method is validated depending on the precision.
3.3.2. Linearity
Linearity is the ability of a method to produce test results that
are directly proportional to the concentrations of the analyte
within a given range. Linear responses were established from
the concentrationeresponse curve of each compound (cate-
chin and epicatechin) on the basis of five standards covering
the concentration range of 1.56e25.00 mg/mL. The acceptance
criterion for linearity is that the correlation coefficient (r2)
should not be <0.990 for the least squares method of the
analysis of the line [25]. The correlation coefficients of
(þ)-catechin and ()-epicatechin were 0.9993 and 0.9989,
respectively (Figure 5). This result demonstrates the linearity
of this method over a wide dynamic range.
3.3.3. Percent recovery of (þ)-catechin and ()-epicatechin in
extract
The recovery rates of (þ)-catechin and ()-epicatechin, shown
in Table 3, were determined at three different concentrations
with triplicate injections by comparing the mean of peak
areas. The mean recoveries of (þ)-catechin in extract were
67.54e90.98% (w/v) when the extract was spiked with pure
(þ)-catechin. The mean recoveries of ()-epicatechin were
58.84e90.75% (w/v) in extract spiked with ()-epicatechin
(Table 3). The recovery percentages of both compounds are
lower, which could be attributable to the interference of the
sample matrix or the slowness of extraction of those com-
pounds from the extract matrix. Moreover, the low recovery is
justified in this case, as the expected recovery is dependent on
the percentage of analyte in thematrix [24], indicating that the
analytical method is validated.
3.3.4. LOD and LOQ
According to International Conference on Harmonization
guideline [26], there are several approaches to determine the
lower LOD and lower LOQ. Visual evaluation, signal/noise
ratio, and the use of SD of the response and the slope of the
calibration curve are the generally used methods. The LOD
and LOQ in the present study were determined based on thelast approach. The LOD was 0.15 mg/mL for (þ)-catechin and
0.28 mg/mL for ()-epicatechin since the peak areas for these
concentrations were distinguishable from the response given
by the blank sample. The LOQ of (þ)-catechin was 0.45 mg/mL,
and that of ()-epicatechin was 0.84 mg/mL. Therefore, both
catechin and epicatechin can be reliably quantified at con-
centrations higher than 1 mg/mL.
Table 3 e Percent recovery of catechin and epicatechin.
Catechin (mg/mL) Epicatechin (mg/mL)
1.56 6.25 25 1.56 6.25 25
Recovery (%, w/v) 67.54 ± 2.30 69.56 ± 1.26 90.98 ± 0.58 58.84 ± 4.13 91.36 ± 0.98 90.75 ± 0.42
Results are presented as mean ± standard deviation of three replicate injections.
Table 4 e Determination of the amount of catechin and
epicatechin from the diluted supernatant of Bulnesis
sarmienti capsules.
Area Amount (mg/mL)
Catechin 70.18 ± 0.81 6.36 ± 0.06
Epicatechin 51.08 ± 4.79 4.47 ± 0.41
Results are presented as mean ± standard deviation of three
replicate injections.
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Specificity of the analytical method ensures that the signals
measured come from the desired compounds, and there is no
interference from diluents, extract materials, and mobile
phase.Photodiodearraydetectionalsosupportedthespecificity
of the method and provided evidence for the homogeneity of
the peaks of analytes. Peaks obtained from recovery experi-
ments were checked for uniformity using UV spectra taken
fromdifferent points of thepeakof interest. Thesespectrawere
superimposed whenever overlaid, showing that there was no
othercoelutingpeaks, inevery instance for eachof theanalytes.
The data obtained in the validation study proved that the pro-
posed method is validated and can be used for the determina-
tion and quantification of catechin and epicatechin.3.4. Quantification of catechin and epicatechin in
different samples
The amounts of catechin and epicatechin in BSAE were deter-
mined to be 1.27% (w/w) and0.71% (w/w), respectively, using the
HPLC analysis. The amounts of these compounds in diluted su-
pernatant of BSAE capsuleswere determined as shown in Table
4. The average amounts of catechin and epicatechin were
6.36 mg/mL and 4.47 mg/mL, respectively, in the supernatant
prepared fromtheencapsulatedextract.Therefore, theamounts
of catechin and epicatechin in a capsule were 636 mg/mL and
447 mg, respectively, which were calculated from the amount in
eachmicroliter, multiplied by the total dilution factor.3.5. HPLC-mass spectroscopic separation
The photodiode array detection of BSAE revealed catechin and
epicatechin with some unidentified compounds. In HPLC-
mass spectrometry (MS) analysis, the dominant isomer yiel-
ded a base peak at m/z 289, secondary ion at m/z 435, and
strong ion at m/z 449, and were assigned for (þ)-catechin and
()-epicatechin (Figure 1). The chromatograms of HPLC-MS
analysis of this extract are shown in Figure 4.4. Conclusion
The aim of method validation was to confirm that the present
method is suitable for its intended purpose. After optimiza-
tion of the HPLC conditions, the described method was
extensively validated in terms of accuracy, precision, line-
arity, LOD, LOQ, and specificity. This proposed method has
proven to be simple, precise, rapid, and reliable. The validated
method provides a good resolution in response to these
compounds. It may be possible to perform quantitative anal-
ysis of plant extracts or herbal medicines having catechin and
epicatechin within a short analysis time by using this single
procedure. BSAE enhance the growth of the four L. acidophilus
strains in vitro. The rapid growth of four L. acidophilus strains
was influenced by the prebiotic activities of catechin and
epicatechin present in BSAE. The findings suggest that BSAE
may promote the survival, colonization, and activity of the
above probiotic strains in the gastrointestinal tract, thereby
resulting in the improvement of their beneficial effects in
health. Further studies are necessary to investigate the above
selected prebiotics in vivo in which the survival, persistence,
and colonization of these probiotics are assessed thoroughly.Conflicts of interests
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